Chloroquine, Malaria Prophylaxis, and COVID-19: An Observation From Endemic Area

References (5)

1. Zang Y, Han X, He M, Shi J, Li Y. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis. Naunyn Schmiedebergs Arch Pharmacol 2021; 394(4): 775–82
2. Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus out- break and imported case. Adv Trop Med Public Health Int 2020; 10: 1–2
3. Tripathy S, Dassarma B, Roy S, Chabalala H, Matsabisa MG. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic. Int J Antimicrob Agents 2020; 56(2): 106028
4. Million M, Gautret P, Colson P, Roussel Y, Dubourg G, Chabriere E, et al. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect 2020; 38: 100709
5. Yao X, Yan X, Wang X, Cai T, Zhang S, Cui C, et al. Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients. Eur J Clin Pharmacol 2021; 77(4): 583–93.